Vivo Capital, LLC Portfolio Holdings

Vivo Capital, LLC

  • $629 Million
  • Q3 2025

Vivo Capital, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $629 Million distributed in 47 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $149M, Terns Pharmaceuticals, Inc. with a value of $52.4M, Trevi Therapeutics, Inc. with a value of $45.5M, Cogent Biosciences, Inc. with a value of $40.1M, and Geron Corp with a value of $37.3M.

Examining the 13F form we can see an increase of $157M in the current position value, from $472M to 629M.

Vivo Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Vivo Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $629 Million
Healthcare: $629 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 47
  • Current Value $629 Million
  • Prior Value $472 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 8 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email